TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:11 | 11/18/24 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | CA | D | P.m | 25 | 1.00 | 0 | 25 | 5 | 529 | D | |||||||||||||||
2/8/24 16:11 | 2/6/24 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | MA | D | M.d | 24 | 1.69 | 0 | 14 | 4 | 376 | D | |||||||||||||||
1/19/24 19:32 | 1/18/24 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | CA | D | S | -1,911 | 19.11 | 0 | -100 | -17 | 504 | I | |||||||||||||||
12/8/22 17:09 | 12/7/22 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | MA | D | P | 28 | 1.30 | 0 | 21 | 6 | 362 | D | |||||||||||||||
5/16/22 16:24 | 5/12/22 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | MA | D | P | 1 | 1.61 | 0 | 1 | 0 | 341 | D | |||||||||||||||
5/12/22 16:35 | 5/10/22 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | MA | D | P.m | 95 | 1.89 | 0 | 50 | 17 | 340 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |